A Study of SHR-1210 in Combination With Carboplatin + Paclitaxel in Subjects With Squamous NSCLC

Clinical trial NCT03668496 · UNKNOWN

Trial details

NCT number: NCT03668496
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Lung Cancer Squamous Cell Lung Cancer Stage IV PD-1 Antibody Chemotherapy Effect

Start date: 2018-11-09
Primary completion: 2020-11-06
Enrollment: 390

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.